Re-Vana Therapeutics, Ltd. | Belfast, Northern Ireland
 Developing next generation long acting biodegradable drug delivery   platform
 News:  Re-Vana Therapeutics Raises $3.25 Million in Pre-Series A Financing
              Dr. Rahhal Interview Re-Vana Therapeutics, Ltd. CEO Michael O'Rourke

---

LensGen, Inc. | Irvine, California
A biomimetic accommodating intraocular lens
News:   OIS Podcast – Ram Rao, CEO LensGen
              LensGen® Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directors
Publication: Long-term biocompatibility of a new fluid-filled, modular  accommodating IOL

---

 Envision Diagnostics, Inc. | Los Angeles, California
 Revolutionizing the eye exam
  News: Envision Diagnostics raises Series A Financing
                                                      Publication:  Automated Pupillometry Using a Prototype Binocular OCT System

---

 DTx Pharma. | San Diego, California
 Enabling delivery of precision RNA therapeutics
 News: Completes $100M Series B to Advance its FALCON™ Platform and RNA Therapeutics
 Publication: Biocentury | DTx: Optimizing RNA therapies for cellular uptake, biodistribution

---

ONL Therapeutics, Inc. | Ann Arbor, Michigan
Pioneering an entirely new approach to preserving sight
News:   ONL Therapeutics Closes $46.9 Million in Series B
              ONL Therapeutics featured on the OIS Retina Podcast with Dr. Rahhal
              ONL Therapeutics Announces First Patient Treated in Phase I Study With ONL1204

---

Trefoil Therapeutics, Inc. | San Diego, California
Developing novel compounds to treat corneal dystrophies
News:  Restoring vision loss with a regenerative therapy
             Trefoil Therapeutics Begins Second Phase 2 “STORM” Clinical Trial
                                                       Publications: Proliferation of Human Corneal Endothelia in Organ Culture Stimulated by                                                                 Wounding and the Engineered Human Fibroblast Growth Factor 1 Derivative TTHX1114
                                                       A Bell-Shaped Dose Response of Topical FGF-1 in Dermal Wound Healing ...

---

 2C Tech Corporation, Inc. | Irvine, California
 Quantum Dots to treat retinal disease 
  Studies:  Library

---

  Qura, Inc. | Boston, Massachusetts
  Implantable intraocular pressure sensor 
  News:  Qura receives strategic investment from Santen Ventures

---

RetroSense Therapeutics, LLC | Irvine, California
(Acquired: Allergan) First in class optogenetics therapy to treat retinal diseases 
News:  Allergan Acquires Gene Therapy Company RetroSense Therapeutics 

---